pfizer inc (PFE:New York Consolidated)
Mikael Dolsten Ph.D.
President of Worldwide Research and Development, Pfizer Inc.
|Age||Total Calculated Compensation||This person is connected to 35 board members in 1 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2014
Prof. Mikael Dolste, Ph.D. has been the President of Worldwide Research and Development at Pfizer Inc. since December 2010. Prof. Dolsten serves as Head of Corporate Division Pharma Research/Discovery at Boehringer Ingelheim with responsibility for approximately 1400 discovery scientists and world-wide research in respiratory, immunology/inflammation, metabolic disease, CNS/pain, oncology and cardiovascular therapies. Prof. Dolsten has spent approximately seventeen years ...
235 East 42nd StreetPhone: 212-733-2323
New York, New York 10017
Board Members Memberships*
Weizmann Institute Of Science
Skåne University Hospital
|Paul Bulcke B.E.||Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee|
|Alan George Lafley||Chairman, Chief Executive Officer, President and Member of Proxy Committee|
The Procter & Gamble Company
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|Joseph Jimenez MBA||Chief Executive Officer|
|Severin Schwan Ph.D.||Chief Executive Officer and Director|
Roche Holding AG
|SFr.5.3M||Compensation as of Fiscal Year 2013.|